REFERENCES
- Postma D S, Kerstjens H A. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: S187–192, [PUBMED], [INFOTRIEVE], [CSA]
- Polosa R, Rorke S, Holgate S T. Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax 2002; 57: 649–654, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Taube C, Holz O, Mücke M, Jörres R A, Magnussen H. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1810–1815, [PUBMED], [INFOTRIEVE], [CSA]
- Mitchell R W, Rühlmann E, Magnussen H, Leff A R, Rabe K F. Passive sensitisation of human bronchi augments smooth muscle shortening velocity and capacity. Am J Physiol 1994; 267: 218–222, [CSA]
- Belvisi M G. Overview of the innervation of the lung. Curr Opin Pharmacol 2002; 2: 211–215, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hogg J C, Chu F, Utokaparch S, Woods R, Elliott W M, Buzatu L, Cherniack R M, Rogers R M, Sciurba F C, Coxson H O, Pare P D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645–2653, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hegele R G, Hayashi S, Hogg J C, Paré P D. Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections. Am J Respir Crit Care Med 1995; 151: 1659–1665, [PUBMED], [INFOTRIEVE], [CSA]
- Tiddens H A, Hofhuis W, Bogaard J M, Hop W C, de Bruin H, Willems L N, de Jongste J C. Compliance, hysteresis, and collapsibility of human small airways. Am J Respir Crit Care Med 1999; 160: 1110–1118, [PUBMED], [INFOTRIEVE], [CSA]
- Verhoeven G T, Verbraak A F, Boere-van der Straat S, Hoogsteden H C, Bogaard J M. Influence of lung parenchymal destruction on the different indexes of the methacholine dose-response curve in COPD patients. Chest 2000; 117: 984–990, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vincenc K S, Black J L, Yan K, Armour C L, Donnelly P D, Woolcock A J. Comparison of in vivo and in vitro responses to histamine in human airways. Am Rev Respir Dis 1983; 128: 875–879, [PUBMED], [INFOTRIEVE], [CSA]
- Armour C L, Black J L, Berend N, Woolcock A J. The relationship between bronchial hyperresponsiveness to methacholine and airway smooth muscle structure and reactivity. Respir Physiol 1984; 58: 223–233, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Armour C L, Lazar N M, Schellenberg R R, Taylor S M, Chan N, Hogg J C, Paré P D. A comparison of in vivo and in vitro human airway reactivity to histamine. Am Rev Respir Dis 1984; 129: 907–910, [PUBMED], [INFOTRIEVE], [CSA]
- Roberts J A, Raeburn D, Rodger I W, Thomson N C. Comparison of in vivo airway responsiveness and in vitro smooth muscle sensitivity to methacholine in man. Thorax 1984; 39: 837–843, [PUBMED], [INFOTRIEVE], [CSA]
- Taylor S M, Paré P D, Armour C L, Hogg J C, Schellenberg R R. Airway reactivity in chronic obstructive pulmonary disease. Failure of in vivo methacholine responsiveness to correlate with cholinergic, adrenergic, or nonadrenergic responses in vitro. Am Rev Respir Dis 1985; 132: 30–35, [PUBMED], [INFOTRIEVE], [CSA]
- Cerrina J, Le Roy Ladurie M, Labat C, Raffestin B, Bayol A, Brink C. Comparison of human bronchial muscle responses to histamine in vivo with histamine and isoproterenol agonists in vitro. Am Rev Respir Dis 1986; 134: 57–61, [PUBMED], [INFOTRIEVE], [CSA]
- de Jongste J C, Mons H, Block R, Bonta I L, Frederiksz A P, Kerrebijn K F. Increased in vitro histamine responses in human small airways smooth muscle from patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1987; 135: 549–553, [PUBMED], [INFOTRIEVE], [CSA]
- Schmidt D T, Jörres R A, Rühlmann E, Rabe K F. Isolated airways from current smokers are hyper-responsive to histamine. Clin Exp Allergy 2001; 31: 1041–1047, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tiddens H A, Paré P D, Hogg J C, Hop W C, Lambert R, de Jongste J C. Cartilaginous airway dimensions and airflow obstruction in human lungs. Am J Respir Crit Care Med 1995; 152: 260–266, [PUBMED], [INFOTRIEVE], [CSA]
- Quanjer P H, Tammeling G J, Cotes J E, Pedersen O F, Peslin R, Yernault J C. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 16: S5–S40, [CSA]
- Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256–1276, For the update of definitions (2004) see: http://www.goldcopd.com/, [PUBMED], [INFOTRIEVE], [CSA]
- Jörres R A, Nowak D, Kirsten D, Grönke L, Magnussen H. A short protocol for methacholine provocation testing adapted to the Rosenthal–Chai dosimeter technique. Chest 1997; 111: 866–869, [CSA]
- Verhoeven G T, Hegmans J P, Mulder P G, Bogaard J M, Hoogsteden H C, Prins J B. Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness. Thorax 2002; 57: 694–700, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Armour C L, McKay K O, Johnson P R, Glanville A R, Black J L. Does the disease state influence the responsiveness of human airways studied in vitro?. J Appl Physiol 1996; 80: 2211–2216, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schmidt D, Watson N, Ruehlmann E, Magnussen H, Rabe K F. Serum immunoglobulin E levels predict human airway reactivity in vitro. Clin Exp Allergy 2000; 30: 233–241, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Oryszczyn M P, Annesi-Maesano I, Charpin D, Paty E, Maccario J, Kauffmann F. Relationships of active and passive smoking to total IgE in adults of the Epidemiological Study of the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy (EGEA). Am J Respir Crit Care Med 2000; 161: 1241–1246, [PUBMED], [INFOTRIEVE], [CSA]
- Sunyer J, Antó J M, Kogevinas M, Soriano J B, Tobias A, Munoz A. Smoking and bronchial responsiveness in nonatopic and atopic young adults. Spanish Group of the European Study of Asthma. Thorax 1997; 52: 235–238, [PUBMED], [INFOTRIEVE], [CSA]
- Barrett E G, Wilder J A, March T H, Espindola T, Bice D E. Cigarette smoke-induced airway hyperresponsiveness is not dependent on elevated immunoglobulin and eosinophilic inflammation in a mouse model of allergic airway disease. Am J Respir Crit Care Med 2002; 165: 1410–1418, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rijcken B, Schouten J P, Mensinga T T, Weiss S T, De Vries K, Van der Lende R. Factors associated with bronchial responsiveness to histamine in a population sample of adults. Am Rev Respir Dis 1993; 147: 1447–1453, [PUBMED], [INFOTRIEVE], [CSA]
- Seow C Y, Wang L, Paré P D. Airway narrowing and internal structural constraints. J Appl Physiol 2000; 88: 527–433, [PUBMED], [INFOTRIEVE], [CSA]
- De Lorme M P, Yang H, Elbon-Copp C, Gao X, Barraclough-Mitchell H, Bassett D J. Hyperresponsive airways correlate with lung tissue inflammatory cell changes in ozone-exposed rats. J Toxicol Environ Health A 2002; 65: 1453–1470, [CROSSREF], [CSA]
- Gelb A F, Schein M, Kuei J, Tashkin D P, Muller N L, Hogg J C, Epstein J D, Zamel N. Limited contribution of emphysema in advanced chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 147: 1157–1161, [PUBMED], [INFOTRIEVE], [CSA]
- Verna V K, Cockcroft D W, Dosman J A. Airway responsiveness to inhaled histamine in chronic obstructive airway disease. Chronic bronchitis vs emphysema. Chest 1988; 94: 457–461, [CSA]
- Riess A, Wiggs B, Verburgt L, Wright J L, Hogg J C, Paré P D. Morphologic determinants of airway responsiveness in chronic smokers. Am J Respir Crit Care Med 1996; 154: 1444–1449, [PUBMED], [INFOTRIEVE], [CSA]
- Hogman M, Almirall J, Mork A C, Roomans G M, Hagelqvist E, Lagerstrand L, Hedenstierna G. Nebulisation of hypertonic saline causes oedema of the airway wall. J Submicrosc Cytol Pathol 1997; 29: 59–64, [PUBMED], [INFOTRIEVE], [CSA]
- Zühlke I E, Kanniess F, Richter K, Nielsen-Gode D, Bohme S, Jorres R A, Magnussen H. Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD. Eur Respir J 2003; 22: 926–930, [CSA]